These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24297094)

  • 21. Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.
    Bultink IEM
    Calcif Tissue Int; 2018 May; 102(5):575-591. PubMed ID: 28900675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Oshagbemi OA; Driessen JHM; Pieffers A; Wouters EFM; Geusens P; Vestergaard P; van den Bergh J; Franssen FME; de Vries F
    Osteoporos Int; 2017 Oct; 28(10):2859-2866. PubMed ID: 28638981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Tamimi I; Nicolau B; Eimar H; Arekunnath Madathil S; Kezouh A; Karp I; Tamimi F
    Osteoporos Int; 2018 Apr; 29(4):849-857. PubMed ID: 29264626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture: A General Population-Based Study.
    Li L; Xie H; Lu N; Esdaile JM; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):259-265. PubMed ID: 31758639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data.
    Ramsey-Goldman R; Dunn JE; Huang CF; Dunlop D; Rairie JE; Fitzgerald S; Manzi S
    Arthritis Rheum; 1999 May; 42(5):882-90. PubMed ID: 10323443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: a nationwide population-based cohort study.
    Lee HS; Chen CY; Huang WT; Chang LJ; Chen SC; Yang HY
    Arch Osteoporos; 2018 Jul; 13(1):80. PubMed ID: 30032473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of type 2 diabetes-related characteristics with fracture risk at different sites.
    van Hulten V; Souverein PC; Starup-Linde J; Viggers R; Klungel OH; Vestergaard P; Brouwers MCJG; van den Bergh JP; Driessen JHM
    Diabetes Obes Metab; 2024 Nov; 26(11):4887-4896. PubMed ID: 39223858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
    Driessen JH; van den Bergh JP; van Onzenoort HA; Henry RM; Leufkens HG; de Vries F
    Diabetes Obes Metab; 2017 Mar; 19(3):421-428. PubMed ID: 27943565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictors of fragility fractures in systemic lupus erythematosus.
    Yee CS; Crabtree N; Skan J; Amft N; Bowman S; Situnayake D; Gordon C
    Ann Rheum Dis; 2005 Jan; 64(1):111-3. PubMed ID: 15608308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.
    Tang XL; Qin L; Kwok AW; Zhu TY; Kun EW; Hung VW; Griffith JF; Leung PC; Li EK; Tam LS
    Osteoporos Int; 2013 Jun; 24(6):1817-26. PubMed ID: 23104200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of systemic lupus erythematosus with a higher risk of cervical but not trochanteric hip fracture: a nationwide population-based study.
    Wang SH; Chang YS; Liu CJ; Lai CC; Chen WS; Chen TJ; Wang SJ
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1674-81. PubMed ID: 23592551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study.
    De Jong HJI; van Staa TP; Lalmohamed A; de Vries F; Vandebriel RJ; Van Loveren H; Klungel OH; Cohen Tervaert JW
    Ann Rheum Dis; 2017 Oct; 76(10):1723-1730. PubMed ID: 28684558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study.
    Hou WH; Chang KC; Li CY; Ou HT
    Br J Clin Pharmacol; 2018 Sep; 84(9):2029-2039. PubMed ID: 29766544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study.
    Majumdar SR; Morin SN; Lix LM; Leslie WD
    Osteoporos Int; 2013 Sep; 24(9):2493-8. PubMed ID: 23572142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of fracture in patients with Parkinson's disease.
    Pouwels S; Bazelier MT; de Boer A; Weber WE; Neef C; Cooper C; de Vries F
    Osteoporos Int; 2013 Aug; 24(8):2283-90. PubMed ID: 23430103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
    Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
    J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model.
    Rees F; Doherty M; Lanyon P; Davenport G; Riley RD; Zhang W; Grainge MJ
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):833-841. PubMed ID: 27588834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragility fractures in lupus patients: Associated factors and comparison of four fracture risk assessment tools.
    Ceccarelli F; Olivieri G; Orefice V; Picciariello L; Natalucci F; Conti F
    Lupus; 2023 Oct; 32(11):1320-1327. PubMed ID: 37698854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
    Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
    Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
    Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.